Key Points Pfizer will pay its 352nd consecutive quarterly dividend on Dec. 7, 2026. A patent cliff, a cash-draining acquisition, and major clinical setbacks could threaten the dividend, but all three would likely need to happen to end it. Pfizer is more likely to navigate the patent cliff and keep funding its dividend at current levels. Motley Fool Issues Rare "Total Conviction" Buy Alert › Pfizer (NYSE: PFE) shareholders should mark Dec. 7, 2026, on their calendars.
Keith Speights
Verified
As seen in:
The Motley Fool (U.S.),
CNN Business,
MSN,
MSN Canada,
MSN Ireland,
MSN Money Canada,
Business Insider,
USA Today,
Yahoo News,
Yahoo News New Zealand,
Aol
and
Investor, author, and regular contributor to The Motley Fool. Views are solely mine.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Keith
Contact Keith, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack